Article Details

RVAC Medicines and A*STAR to Build Capabilities for mRNA Production in Singapore

Retrieved on: 2022-11-21 11:50:52

Tags for this article:

Click the tags to see associated articles and topics

RVAC Medicines and A*STAR to Build Capabilities for mRNA Production in Singapore. View article details on hiswai:

Excerpt

Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up